Medicinal product name | Methotrexate "Ebewe" 2.5 mg tablets |
||||||
---|---|---|---|---|---|---|---|
Pharmaceutical form | Tablet | ||||||
Strength | 2.5 mg | ||||||
Information from the MAH on shortages |
Not available predicted availability date: not notified |
||||||
Availability of medicinal product |
|
||||||
Legal status | NHS Reimbursed medicines |
Prescription (Pr.)||||||
Package leaflet | 17-08-2023 | ||||||
Summary of product characteristics | 17-08-2023 | ||||||
Risk minimisation measures | Izglītojošie materiāli ārstam Izglītojošie materiāli farmaceitam Izglītojošie materiāli pacientam Vēstule veselības aprūpes speciālistam | ||||||
ATC code | L01BA01 – Antineoplastic agents | ||||||
Information for Marketing authorisation holders | View |
Medicinal products (6)
Availability of medicinal product | Wholesalers | Package size, content | Primary packaging | Maximum admissible pharmacy price (€ incl. VAT) | Product No. | Labelling |
---|---|---|---|---|---|---|
Not available (according to the information provided by wholesalers) Permitted to distribute until Jul 7, 2025 Product suspended from the medicinal product register, distribution permitted for a limited time span |
currently no information on availability from any wholesaler |
N30 (2,5 mg) |
Polypropylene | 05-0313-01 | ||
Is available (according to the information provided by wholesalers) (27 containers) Permitted to distribute until Jul 7, 2025 Product suspended from the medicinal product register, distribution permitted for a limited time span |
Tamro, Magnum Medical |
N50 (2,5 mg) |
Polypropylene |
€ 7.29 * |
05-0313-02 | |
Not available (according to the information provided by wholesalers) Permitted to distribute until Jul 7, 2025 Product suspended from the medicinal product register, distribution permitted for a limited time span |
currently no information on availability from any wholesaler |
N100 (2,5 mg) |
Polypropylene | 05-0313-03 | ||
Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N30 (2,5 mg) |
PVC/PVDC/Al blister | 05-0313-04 |
Labelling text Jun 30, 2022 Labelling text Jun 30, 2022 |
|
Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N50 (2,5 mg) |
PVC/PVDC/Al blister | 05-0313-05 |
Labelling text Jun 30, 2022 Labelling text Jun 30, 2022 |
|
Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N100 (2,5 mg) |
PVC/PVDC/Al blister | 05-0313-06 |
Labelling text Jun 30, 2022 Labelling text Jun 30, 2022 |
Registration information
Marketing authorisation No. | 05-0313 |
---|---|
Date of authorisation | Aug 1, 2005 |
Marketing authorisation holder, country | Sandoz d.d., Slovenia |